| Belimumab and Rituximab Combination Therapy for the Treatment of Diffuse Cutaneous Systemic Sclerosis (NCT03844061) | Hospital for Special Surgery, New York | 2019-07-29 |
| NAPOLI-2: Fluorouracil, Leucovorin, and Nanoliposomal Irinotecan in Biliary Cancer (NCT04005339) | Georgetown University | 2019-07-29 |
| Safety, Tolerability, and Efficacy of Monotherapy and Combination Regimens in Participants With Nonalcoholic Steatohepatitis (NASH) (NCT03987074) | Gilead Sciences | 2019-07-29 |
| The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer (NCT03841617) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2019-07-29 |
| FMT in Cirrhosis and Hepatic Encephalopathy (NCT03796598) | VA Office of Research and Development | 2019-07-29 |
| Intracameral Levofloxacin (0.5%) vs Intracameral Cefuroxime (NCT04212078) | National University of Malaysia | 2019-07-29 |
| A Study to Evaluate Lucitanib in Combination With Nivolumab in Patients With a Solid Tumor (NCT04042116) | Clovis Oncology, Inc. | 2019-07-29 |
| A Multiple Ascending Dose Study of Pegozafermin in Participants With Biopsy Confirmed Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) and at High Risk of NASH (NCT04048135) | 89bio, Inc. | 2019-07-29 |
| Study of Binimetinib With Encorafenib in Adults With Recurrent BRAF V600-Mutated HGG (NCT03973918) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-07-29 |
| Second-Line Chemotherapy Combined With Endostatin for Recurrent/Metastatic HN Epithelial Tumors (NCT03989830) | Sun Yan | 2019-07-29 |
| The Use of Dantrolene to Improve Analgesia in Posterior Lumbar Surgery (NCT03762109) | Beth Israel Deaconess Medical Center | 2019-07-29 |
| Reduced Intensity Radio-chemotherapy for Stage IIA/B Seminoma (NCT03937843) | Swiss Cancer Institute | 2019-07-29 |
| A Phase II Study of Neoadjuvant E7 TCR T Cell Immunotherapy for Borderline Resectable and Unresectable Stage I HPV-Associated Oropharyngeal Cancer (NCT04044950) | National Cancer Institute (NCI) | 2019-07-29 |
| A Study of Cusatuzumab Plus Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia Who Are Not Candidates for Intensive Chemotherapy (NCT04023526) | OncoVerity, Inc. | 2019-07-29 |
| Dose-Ranging Efficacy and Safety Study of Topical Rapamycin Cream for Facial Angiofibroma Associated With Tuberous Sclerosis Complex (NCT03826628) | Dermatology Specialties Limited Partnership | 2019-07-28 |
| An Study to Evaluate Safety and Efficacy of QL-007 Tablets in Combination With Entecavir or Tenofovir in Patients With Chronic Hepatitis b Who Have Received Nucleoside (Acid) Therapy (NCT04157257) | Qilu Pharmaceutical Co., Ltd. | 2019-07-26 |
| Ponatinib in Advanced or Metastatic Medullary Thyroid Cancer (NCT03838692) | Antonio Fojo | 2019-07-26 |
| An Study to Evaluate Safety and Efficacy of QL-007 Tablets in Combination With Tenofovir in Naive Patients With Chronic Hepatitis b (NCT04157699) | Qilu Pharmaceutical Co., Ltd. | 2019-07-26 |
| Rehabilitation and Cortical Remodeling After Surgical Intervention for Spinal Cord Injury (NCT04041063) | Burke Medical Research Institute | 2019-07-26 |
| Study of the Efficacy of Lenvatinib Combined With Denosumab in the Treatment of Patients With Predominant Bone Metastatic Radioiodine Refractory Differentiated Thyroid Carcinomas (NCT03732495) | Centre Leon Berard | 2019-07-26 |
| First-line Chemotherapy With Temozolomide Alone for Non-enhancing Adult Brainstem Gliomas, With a Diffuse Subtype and Showing Clinical and/or Radiological Infiltrative Pattern of Progression (NCT03932981) | Assistance Publique - Hôpitaux de Paris | 2019-07-26 |
| PD-1 Antibody + Apatinib Mesylate in 2+ Line Serum AFP-elevated Gastric Adenocarcinoma (NCT04006821) | China Medical University, China | 2019-07-25 |
| Extension Study of IONIS-GHR-LRx Administered to Participants With Acromegaly Being Treated With Long-acting Somatostatin Receptor Ligands (NCT03967249) | Ionis Pharmaceuticals, Inc. | 2019-07-25 |
| Savolitinib in Treating Patients With MET Amplified Metastatic or Unresectable Colorectal Cancer (NCT03592641) | National Cancer Institute (NCI) | 2019-07-25 |
| Antimicrobial Therapy for Ulcerative Colitis (UC) (NCT03986996) | Wolfson Medical Center | 2019-07-25 |
| Effects of Prolonged Delivery of Nitric Oxide Gas on Plasma Reduction-Oxidation Reactions in Cardiac Surgical Patients (NCT04022161) | Massachusetts General Hospital | 2019-07-25 |
| Study of Osimertinib With and Without Ramucirumab in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) (NCT03909334) | Xiuning Le | 2019-07-25 |
| Ipilimumab, Nivolumab, and Radiation Therapy in Treating Patients With HPV Positive Advanced Oropharyngeal Squamous Cell Carcinoma (NCT03799445) | M.D. Anderson Cancer Center | 2019-07-25 |
| A Study to Investigate the Safety and Efficacy of Elsubrutinib and Upadacitinib Given Alone or in Combination in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE) (NCT03978520) | AbbVie | 2019-07-25 |
| Rogaratinib in Patients With Advanced Pretreated Squamous-cell Non-small Cell Lung Cancer (SQCLC) (NCT03762122) | Swiss Cancer Institute | 2019-07-25 |
| Targeted Treatment for ALK Positive Patients Who Have Previously Been Treated for Non-squamous Non-small Cell Lung Cancer (NCT03737994) | National Cancer Institute (NCI) | 2019-07-25 |
| Medication Maintenance Therapy in Community Pharmacy Settings (NCT04139213) | Lifespan | 2019-07-25 |
| Use of Antibiotic Irrigation to Decrease Wound Infections in Pediatric Perforated Appendicitis (NCT04039750) | Prisma Health-Upstate | 2019-07-25 |
| Medication Responsiveness in Parkinson's Disease (NCT04185740) | KU Leuven | 2019-07-25 |
| Testing the Safety and Tolerability of CX-4945 in Patients With Recurrent Medulloblastoma Who May or May Not Have Surgery (NCT03904862) | Pediatric Brain Tumor Consortium | 2019-07-25 |
| Impact of Nuedexta on Bulbar Physiology and Function in ALS (NCT03883581) | University of Florida | 2019-07-25 |
| Aspirin as an Ultraviolet (UV) Protectant in Human Subjects at Risk for Melanoma (NCT04066725) | University of Utah | 2019-07-25 |
| SUV on PSMA PET/CT in Non-Prostate Tumors (NCT03841760) | Sir Mortimer B. Davis - Jewish General Hospital | 2019-07-25 |
| CPX-351 Therapy for MDS After Hypomethylating Agent Failure (NCT03957876) | Case Comprehensive Cancer Center | 2019-07-25 |
| Feasibility and Tolerance of Nivolumab Neoadjuvant Immunotherapy in High Risk HPV Driven Oropharynx Cancer (NCT03838263) | UNICANCER | 2019-07-25 |
| Volume Expansion With Albumin vs. Crystalloid and Expiratory Lung Impedance (NCT04037644) | University of Milan | 2019-07-24 |
| Camrelizumab Combined With FOLFOX Neoadjuvant Therapy for Resectable Gastric and Gastroesophageal Junctional Adenocarcinoma (NCT03939962) | Henan Cancer Hospital | 2019-07-24 |
| PAT-1251 in Treating Patients With Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocytosis Myelofibrosis (NCT04054245) | M.D. Anderson Cancer Center | 2019-07-24 |
| Testing BVD-523FB (Ulixertinib) as Potentially Targeted Treatment in Cancers With Genetic Changes (MATCH - Subprotocol Z1L) (NCT06400225) | National Cancer Institute (NCI) | 2019-07-24 |
| Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES) (NCT03884075) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2019-07-24 |
| Olorinab in Irritable Bowel Syndrome With Predominant Constipation (IBS-C) and Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D) (NCT04043455) | Arena Pharmaceuticals | 2019-07-24 |
| Safety and Efficacy of SM934 Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus (NCT03951259) | RenJi Hospital | 2019-07-24 |
| Safety and Efficacy Study of TQ-B3101 in Patients With ROS1-positive Non-Small Cell Lung Cancer (NSCLC) (NCT03972189) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2019-07-24 |
| Palliative RT & Anti-PD-1/PD-L1 Checkpoint Blockade in Metastatic Merkel Cell Carcinoma (NCT03988647) | Stanford University | 2019-07-24 |
| [177Lu]-NeoB in Patients With Advanced Solid Tumors and With [68Ga]-neoB Lesion Uptake (NCT03872778) | Advanced Accelerator Applications | 2019-07-24 |
| Study to Evaluate the Efficacy and Safety of Selonsertib in Participants With Moderate to Advanced Diabetic Kidney Disease (NCT04026165) | Gilead Sciences | 2019-07-24 |
| Pilot Randomized Trial With Flecainide in ARVC Patients (NCT03685149) | University of Rochester | 2019-07-23 |
| A Study of Verinurad and Allopurinol in Patients With Chronic Kidney Disease and Hyperuricaemia (NCT03990363) | AstraZeneca | 2019-07-23 |
| ASCEND GO-2: Study of RVT-1401 for the Treatment of Participants With Active, Moderate to Severe Graves' Ophthalmopathy ( GO ) (NCT03938545) | Immunovant Sciences GmbH | 2019-07-23 |
| Neoadjuvant Cemiplimab for the Treatment of Resectable NSCLC, HCC, and HNSCC in Adult Patients (NCT03916627) | Regeneron Pharmaceuticals | 2019-07-23 |
| Screening and Multiple Intervention on Lung Epidemics (NCT03654105) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2019-07-23 |
| Two-Part, Phase Ib/II, Open Label, Single-Arm, Multi-center Study to Evaluate the Safety and Efficacy of Varlitinib in Combination With Weekly Paclitaxel in EGFR/HER2 Co-expressing Advanced or Metastatic Gastric Cancer Patients (NCT05400915) | Yonsei University | 2019-07-23 |
| A Study to Evaluate Neoadjuvant Sonidegib Followed by Surgery or Imiquimod in the Management of Basal Cell Carcinoma (NCT03534947) | Melanoma Institute Australia | 2019-07-23 |
| A Trial of CHOP-R Therapy, With or Without Acalabrutinib, in Patients With Newly Diagnosed Richter's Syndrome (NCT03899337) | University of Birmingham | 2019-07-23 |
| Study of TAK-935 as an Adjunctive Therapy in Adult Participants With Complex Regional Pain Syndrome (CRPS) (NCT03990649) | Millennium Pharmaceuticals, Inc. | 2019-07-23 |
| Maximal Use Study of Tapinarof Cream, 1% in Adults With Extensive Plaque Psoriasis (NCT04042103) | Organon and Co | 2019-07-23 |
| INRT-AIR: A Prospective Phase II Study of Involved Nodal Radiation Therapy (NCT03953976) | University of Texas Southwestern Medical Center | 2019-07-23 |
| Dose-Ranging Study of ST-920, an AAV2/6 Human Alpha Galactosidase A Gene Therapy in Subjects With Fabry Disease (STAAR) (NCT04046224) | Sangamo Therapeutics | 2019-07-23 |
| Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment in Patients With Moderate to Severe Psoriasis (NCT03392311) | Guangdong Provincial Hospital of Traditional Chinese Medicine | 2019-07-23 |
| A Study of the C3 Complement Inhibitor AMY-101 in Adults With Gingivitis (NCT03694444) | Amyndas Pharmaceuticals S.A. | 2019-07-22 |
| Postpartum Low-Dose Aspirin and Preeclampsia (NCT03667326) | Columbia University | 2019-07-22 |
| Axitinib and Avelumab in Treating Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma (NCT03990571) | M.D. Anderson Cancer Center | 2019-07-22 |
| A Study in Parkinson's Disease in Patients With Moderate to Severe Dyskinesia (NCT03956979) | Contera Pharma | 2019-07-22 |
| Trial of Netarsudil for Acceleration of Corneal Endothelial Restoration (NCT03971357) | Price Vision Group | 2019-07-22 |
| Topical Acetaminophen for Itch Relief: a Proof of Concept Study in Healthy Subjects (NCT03997851) | University of Miami | 2019-07-22 |
| A Safety and Efficacy Study Evaluating CTX110 in Subjects With Relapsed or Refractory B-Cell Malignancies (CARBON) (NCT04035434) | CRISPR Therapeutics AG | 2019-07-22 |
| Abiraterone Acetate, Prednisone, and Apalutamide in Treating Patients With Hormone-Naive Metastatic Prostate Cancer (NCT03821792) | M.D. Anderson Cancer Center | 2019-07-22 |
| Preoperative Immunotherapy (Pembrolizumab) for Patients With Colorectal Cancer and Resectable Hepatic Metastases (NCT03844750) | Chloe Atreya, MD, PhD | 2019-07-22 |
| Phase II Study of Short Course FOLFOX Chemotherapy With Either Nivolumab or Nivolumab + Radiation in the First Line Treatment of Metastatic or Unresectable Gastroesophageal Cancers (BMS Protocol CA209-76L) (NCT04021108) | Weill Medical College of Cornell University | 2019-07-22 |
| Metabolic Cofactor Supplementation in Obese Patients With Non-Alcoholic Fatty Liver Disease (NCT04330326) | ScandiBio Therapeutics AB | 2019-07-20 |
| Nitazoxanide as a New Local Adjunctive to Nonsurgical Treatment of Moderate Periodontitis (NCT04768530) | Maha Talaab | 2019-07-20 |
| A PhaseⅡ of Injection for Recombinant Human Tissue Plasminogen Kinase Derivative in Treatment of Acute Ischemic Stroke. (NCT04028518) | Angde Biotech Pharmaceutical Co., Ltd. | 2019-07-20 |
| Sintilimab in Combination With Nab-paclitaxel in Patients With HNSCC (Head and Neck Squamous Cell Carcinoma ) (NCT03975270) | Shengyu Zhou | 2019-07-20 |
| Autologous Platelet-rich Plasma to Improve Responsiveness and Embryo Quality in Patients With Poor Ovarian Response (NCT05105724) | Nanjing University | 2019-07-20 |
| The Benefit of Bermekimab in Patients With Systemic Sclerosis (NCT04045743) | Hellenic Institute for the Study of Sepsis | 2019-07-19 |
| A Study of the Drug Letermovir (LTV) as Prevention for Recurrent of Cytomegalovirus (CMV) Infection (NCT04017962) | Memorial Sloan Kettering Cancer Center | 2019-07-19 |
| Study of Anlotinib Hydrochloride and Toripalimab in Subjects With Unresectable or Metastatic Undifferentiated Pleomorphic Sarcoma (NCT03946943) | Di Wu | 2019-07-19 |
| The EndoBARR Trial (Endometrial Bevacizumab, Atezolizumab, Rucaparib) (NCT03694262) | Medical College of Wisconsin | 2019-07-19 |
| Regorafenib and PD-1 Antibody in Combination With Radiotherapy for pMMR/MSS Metastatic Colorectal Cancer (NCT04030260) | Sun Yat-sen University | 2019-07-19 |
| Determining Whether Durvalumab in Combination With Radiation Therapy Can Prevent the Progression of Non-Small Cell Lung Cancer (NCT03999710) | Memorial Sloan Kettering Cancer Center | 2019-07-19 |
| A Study of Switching to RPV Plus Other ARVs in HIV-1-infected Children (Aged 2 to <12 Years) Who Are Virologically Suppressed (NCT04012931) | Janssen Research & Development, LLC | 2019-07-18 |
| Bisantrene for Relapsed /Refractory AML (NCT03820908) | Sheba Medical Center | 2019-07-18 |
| A Clinical Study to Test Long Term Safety of GLPG1690 for Patients With Systemic Sclerosis (NCT03976648) | Lakefront Biotherapeutics NV | 2019-07-18 |
| AM-125 in the Treatment of Acute Peripheral Vertigo Following Neurosurgery (NCT03908567) | Auris Medical AG | 2019-07-18 |
| A Double-blind Study to Assess 2 Doses of an Investigational Product for 16 Weeks in Participants With Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus (NCT03969719) | Pfizer | 2019-07-18 |
| An Efficacy Study of Adjuvant Treatment With the Personalized Cancer Vaccine mRNA-4157 and Pembrolizumab in Participants With High-Risk Melanoma (KEYNOTE-942) (NCT03897881) | ModernaTX, Inc. | 2019-07-18 |
| A Study of a Personalized Cancer Vaccine Targeting Shared Neoantigens (NCT03953235) | Gritstone bio, Inc. | 2019-07-18 |
| VAC071: A Study to Assess Efficacy of the ChAd63/MVA PvDBP Vaccines (NCT04009096) | University of Oxford | 2019-07-18 |
| Anlotinib Hydrochloride Versus Imatinib Mesylate in Locally Advanced, Unresectable or Metastatic Chordoma (NCT04042597) | Peking University People's Hospital | 2019-07-18 |
| Study of Efficacy and Safety of LOU064 in Inadequately Controlled Asthma Patients (NCT03944707) | Novartis Pharmaceuticals | 2019-07-18 |
| Encorafenib and Binimetinib Before Local Treatment in Patients With BRAF Mutant Melanoma Metastatic to the Brain (NCT03898908) | Grupo Español Multidisciplinar de Melanoma | 2019-07-18 |
| Biomarker Guided Treatment in DLBCL (NCT04025593) | Ruijin Hospital | 2019-07-17 |
| Testing the Combination of Two Approved Chemotherapy Drugs and Radiation Prior to Surgery in Localized Pancreatic Cancer (NCT03492671) | Loma Linda University | 2019-07-17 |
| Clinical Trial Evaluating FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab and Tremelimumab in Second-line Treatment of Patients With Advanced Gastric or Gastro-oesophageal Junction Adenocarcinoma (NCT03959293) | Federation Francophone de Cancerologie Digestive | 2019-07-17 |
| Phase 2/3 Study to Evaluate PK, Safety & Efficacy of INM004 in STEC Positive Pediatric Patients for Prevention of HUS (NCT04132375) | Inmunova S.A. | 2019-07-17 |